Warning: The NCBI web site requires JavaScript to function. more...
Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax.
Mansour M, Pohajdak B, Kast WM, Fuentes-Ortega A, Korets-Smith E, Weir GM, Brown RG, Daftarian P.
J Transl Med. 2007 Apr 23;5:20.PMID: 17451606 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations
Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.
Daftarian PM, Mansour M, Pohajdak B, Fuentes-Ortega A, Korets-Smith E, Macdonald L, Weir G, Brown RG, Kast WM.
J Transl Med. 2007 Jun 7;5:26.PMID: 17555571 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations
Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
Davila E, Kennedy R, Celis E.
Cancer Res. 2003 Jun 15;63(12):3281-8.PMID: 12810660 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
Dezfouli S, Hatzinisiriou I, Ralph SJ.
Immunol Cell Biol. 2003 Dec;81(6):459-71.PMID: 14636243 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H, Kishida T, Hirai H, Satoh E, Ohashi S, Takeuchi M, Kubo T, Kita M, Iwakura Y, Imanishi J, Mazda O.
Mol Ther. 2002 May;5(5 Pt 1):609-16.PMID: 11991752 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion.
Daftarian P, Mansour M, Benoit AC, Pohajdak B, Hoskin DW, Brown RG, Kast WM.
Vaccine. 2006 Jun 12;24(24):5235-44. Epub 2006 Apr 18.PMID: 16675074 [PubMed - indexed for MEDLINE]Related citations
Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
Davila E, Celis E.
J Immunol. 2000 Jul 1;165(1):539-47.PMID: 10861094 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
Jérôme V, Graser A, Müller R, Kontermann RE, Konur A.
J Immunother. 2006 May-Jun;29(3):294-305.PMID: 16699372 [PubMed - indexed for MEDLINE]Related citations
Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
Eur J Immunol. 2009 Oct;39(10):2725-36.PMID: 19637230 [PubMed - indexed for MEDLINE]Related citations
Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF.
Cancer Res. 2004 Aug 15;64(16):5830-8.PMID: 15313927 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.
Bellone M, Cantarella D, Castiglioni P, Crosti MC, Ronchetti A, Moro M, Garancini MP, Casorati G, Dellabona P.
J Immunol. 2000 Sep 1;165(5):2651-6.PMID: 10946294 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
van Elsas A, Hurwitz AA, Allison JP.
J Exp Med. 1999 Aug 2;190(3):355-66.PMID: 10430624 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
Cancer Res. 2007 Mar 15;67(6):2881-92.PMID: 17363612 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.
Lu J, Higashimoto Y, Appella E, Celis E.
J Immunol. 2004 Apr 1;172(7):4575-82.PMID: 15034075 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Vaccination with activated B cells pulsed with tumor-lysates can induce tumor-specific CD4+ T cells in vivo.
Ito O, Harada M, Takenoyama M, Tamada K, Li T, Abe K, Fujie H, Nomoto K.
Immunobiology. 1998 Jul;199(1):133-47.PMID: 9717673 [PubMed - indexed for MEDLINE]Related citations
NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D, Gu P, Pan PY, Li Q, Sato AI, Chen SH.
Int J Cancer. 2004 Apr 20;109(4):499-506.PMID: 14991570 [PubMed - indexed for MEDLINE]Related citations
[Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury]
Tan XH, Wan YH.
Zhonghua Yi Xue Za Zhi. 2005 Jun 22;85(23):1596-600. Chinese. PMID: 16185524 [PubMed - indexed for MEDLINE]Related citations
Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines.
van Slooten ML, Storm G, Zoephel A, Küpcü Z, Boerman O, Crommelin DJ, Wagner E, Kircheis R.
Pharm Res. 2000 Jan;17(1):42-8.PMID: 10714607 [PubMed - indexed for MEDLINE]Related citations
Murine B16 melanoma vaccination-induced tumor immunity: identification of specific immune cells and functions involved.
Wu TY, Fleischmann WR Jr.
J Interferon Cytokine Res. 2001 Dec;21(12):1117-27.PMID: 11798470 [PubMed - indexed for MEDLINE]Related citations
Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
Kudo-Saito C, Schlom J, Hodge JW.
Clin Cancer Res. 2005 Mar 15;11(6):2416-26.PMID: 15788693 [PubMed - indexed for MEDLINE]Free ArticleRelated citations
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on